203 related articles for article (PubMed ID: 11033310)
1. Melanocortins and the brain: from effects via receptors to drug targets.
Adan RA; Gispen WH
Eur J Pharmacol; 2000 Sep; 405(1-3):13-24. PubMed ID: 11033310
[TBL] [Abstract][Full Text] [Related]
2. New vistas for melanocortins. Finally, an explanation for their pleiotropic functions.
Strand FL
Ann N Y Acad Sci; 1999; 897():1-16. PubMed ID: 10676431
[TBL] [Abstract][Full Text] [Related]
3. Melanocortins and cardiovascular regulation.
Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
5. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides.
Tatro JB
Neuroimmunomodulation; 1996; 3(5):259-84. PubMed ID: 9218248
[TBL] [Abstract][Full Text] [Related]
6. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.
MacNeil DJ; Howard AD; Guan X; Fong TM; Nargund RP; Bednarek MA; Goulet MT; Weinberg DH; Strack AM; Marsh DJ; Chen HY; Shen CP; Chen AS; Rosenblum CI; MacNeil T; Tota M; MacIntyre ED; Van der Ploeg LH
Eur J Pharmacol; 2002 Aug; 450(1):93-109. PubMed ID: 12176114
[TBL] [Abstract][Full Text] [Related]
7. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.
MacNeil DJ; Howard AD; Guan X; Fong TM; Nargund RP; Bednarek MA; Goulet MT; Weinberg DH; Strack AM; Marsh DJ; Chen HY; Shen CP; Chen AS; Rosenblum CI; MacNeil T; Tota M; MacIntyre ED; Van der Ploeg LH
Eur J Pharmacol; 2002 Apr; 440(2-3):141-57. PubMed ID: 12007532
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity analysis for the effects of gamma-MSH/ACTH-like peptides on cerebral hemodynamics in rats.
Van Bergen P; Van Der Vaart JG; Kasbergen CM; Versteeg DH; De Wildt DJ
Eur J Pharmacol; 1996 Dec; 318(2-3):357-68. PubMed ID: 9016926
[TBL] [Abstract][Full Text] [Related]
9. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.
Adan RA; Oosterom J; Ludvigsdottir G; Brakkee JH; Burbach JP; Gispen WH
Eur J Pharmacol; 1994 Nov; 269(3):331-7. PubMed ID: 7895772
[TBL] [Abstract][Full Text] [Related]
10. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception.
Starowicz K; Przewłocka B
Life Sci; 2003 Jul; 73(7):823-47. PubMed ID: 12798410
[TBL] [Abstract][Full Text] [Related]
11. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
[TBL] [Abstract][Full Text] [Related]
12. Melanocortins and their receptors and antagonists.
Voisey J; Carroll L; van Daal A
Curr Drug Targets; 2003 Oct; 4(7):586-97. PubMed ID: 14535656
[TBL] [Abstract][Full Text] [Related]
13. Obesity, diabetes and functions for proopiomelanocortin-derived peptides.
Mountjoy KG; Wong J
Mol Cell Endocrinol; 1997 Apr; 128(1-2):171-7. PubMed ID: 9140088
[TBL] [Abstract][Full Text] [Related]
14. Melanocortins and the treatment of nervous system disease. Potential relevance to the skin?
Gispen WH; Adan RA
Ann N Y Acad Sci; 1999 Oct; 885():342-9. PubMed ID: 10816665
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene.
Desarnaud F; Labbe O; Eggerickx D; Vassart G; Parmentier M
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):367-73. PubMed ID: 8172596
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of melanocortin peptides. Possible role in astrocyte regulation.
Zohar M; Salomon Y
J Mol Neurosci; 1993; 4(1):55-62. PubMed ID: 8391297
[TBL] [Abstract][Full Text] [Related]
17. Evidence that alpha-MSH induced grooming is not primarily mediated by any of the cloned melanocortin receptors.
Sanchez MS; Celis ME; Schiöth HB
Neuropeptides; 2000 Apr; 34(2):77-82. PubMed ID: 10985923
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of the melanocortin peptides required for activation of melanocortin-3 and melanocortin-4 receptors.
Miwa H; Gantz I; Konda Y; Shimoto Y; Yamada T
J Pharmacol Exp Ther; 1995 Apr; 273(1):367-72. PubMed ID: 7714790
[TBL] [Abstract][Full Text] [Related]
19. Synthetic melanocortin receptor agonists and antagonists.
Lerner MR
Ann N Y Acad Sci; 1999 Oct; 885():153-60. PubMed ID: 10816648
[TBL] [Abstract][Full Text] [Related]
20. Brain melanocortin receptors: from cloning to function.
Adan RA; Gispen WH
Peptides; 1997; 18(8):1279-87. PubMed ID: 9396074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
